Answers are grounded in this paper and cite their sources.
Background: Hepato cellular carcinoma (HCC) represents a challenging malignancy of worldwide importance; it is the sixth most common cancer and the third most common cause of cancer-related death globally.Alcohol, tobacco, obesity, diabetes and viral etiology interact to increase the risk of HCC in patients with chronic liver diseases.Smoking is a well documented risk factor for many cancers and can play role in cancer development in patients with liver diseases.Egypt has a significant prevalence of HBV, HCV, bilharzial infections and smoking which may allow us to identify a high-risk group for HCC among patients with chronic liver diseases and cirrhosis.Aim: The aim of this study is to evaluate the impact of smoking as a co-factor for HCC development in Egyptian patients with chronic hepatitis B and/or C with or without Schistosomal infestation.Patients and method: A case control study was conducted on 320 Egyptian patients with chronic liver disease (CLD): 160 patients with HCC (Group I) and 160 patients without focal lesion (Group II) as a control group.All patients were assigned to full history taking with emphasis on special habits especially smoking, family history; clinical examination, laboratory investigations, abdominal ultrasound, rectal snip for bilharzial infestation and liver biopsy was conducted in some cases when imaging was inconclusive.Results: There was no statistical significant difference between HCC cases and control group as regards age, gender nor residence.Out of 320 patients enrolled in this study, only 95(29.69%)patients were non smokers, most patients were smokers 225(70.31%).Among the smokers, males were more than females and most of them were heavy smokers.The HCC patients were found more with heavy smoking than control patients.All smokers were liable for developing HCC 1.8times more than non smokers (OR: 1.8, CI: 0.89-3.32)while heavy smokers were 3.15times more liable than non smokers (OR: 3.15, CI: 1.45-7).Smoking men with were liable to develop HCC 2.63times more than non smokers (OR: 2.63, CI: 1.06-5.83)and heavy smokers 2.55times more than non smokers (OR: 2.55, CI: 0.96-6.35),urban smokers were liable to develop HCC 3.57times more than non smokers (OR: 3.57, CI: 1.15-11.58)and heavy smokers 3.48times more than non smokers (OR: 3.48, CI: 0.86-13.9);Smokers with chronic HCV infection were liable to develop HCC 1.51times more than non smokers (OR: 1.51, CI: 0.60-2.94)and heavy smokers 2.6times more than non smokers (OR: 2.6, CI: 0.95-5.96).Smokers with cirrhosis were liable to develop HCC 2.17 times more than non smokers (OR: 2.17, CI: 0.93-5.07)and heavy smokers 4times more than non smokers (OR: 4, CI: 1.95-13.10). Conclusion:The study revealed that smoking for long duration in CLD (chronic HBV, HCV infections and liver cirrhosis) is a highly risk factor for development of HCC among Egyptians.Recommendations: Many efforts are needed to help and promote complete cessation of smoking generally and specially in patients with chronic liver diseases.Follow up of all patients with CLD especially smokers is needed to detect early focal lesion.
No takes yet. Share an insight, caveat, or question.
Nabil M.G. Alnoomani (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: